Literature DB >> 20923298

Sinonasal glomangiopericytoma: case report with emphasis on the differential diagnosis.

Monisha Dandekar1, Jonathan B McHugh.   

Abstract

Glomangiopericytoma (sinonasal-type hemangiopericytoma) is an uncommon sinonasal neoplasm with a perivascular myoid phenotype. This tumor differs from conventional soft tissue hemangiopericytoma in location, biologic behavior, and histologic features. The proposed cell of origin is a modified perivascular glomuslike myoid cell. Glomangiopericytoma is an indolent tumor that tends to arise in the sinonasal tract of older adults and has a low malignant potential with excellent prognosis after surgical resection. Histologically, this lesion is composed of a diffuse, subepithelial proliferation of bland, uniform, closely packed spindled cells growing in a variety of patterns. A distinctive vascular network composed of variably sized vascular channels, the smaller of which demonstrate perivascular hyalinization, is often present. We report the case of a 48-year-old woman with epistaxis and nasal obstruction who was diagnosed with glomangiopericytoma and discuss the histologic differential diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20923298     DOI: 10.5858/2010-0233-CR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  13 in total

1.  Glomangiopericytoma Versus Solitary Fibrous Tumor: an Omental Tumor with Unusual Diagnostic Dilemma.

Authors:  K Jayaprakash Shetty; Chandrika Rao; H L Kishan Prasad
Journal:  Indian J Surg Oncol       Date:  2016-06-11

2.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

Review 3.  Sinonasal tumors: a clinicopathologic update of selected tumors.

Authors:  Pieter J Slootweg; Alfio Ferlito; Antonio Cardesa; Lester D R Thompson; Jennifer L Hunt; Primož Strojan; Robert P Takes; Asterios Triantafyllou; Julia A Woolgar; Alessandra Rinaldo; Kenneth O Devaney; Leon Barnes
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-18       Impact factor: 2.503

4.  Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic Study.

Authors:  Steven C Smith; William E Gooding; Matthew Elkins; Rajiv M Patel; Paul W Harms; Andrew S McDaniel; Nallasivam Palanisamy; Cora Uram-Tuculescu; Bonnie B Balzer; David R Lucas; Raja R Seethala; Jonathan B McHugh
Journal:  Am J Surg Pathol       Date:  2017-12       Impact factor: 6.394

5.  Sinonasal Glomangiopericytoma with Prolonged Postsurgical Follow-Up.

Authors:  Alex J Gordon; Michael R Papazian; Michael Chow; Aneek Patel; Dimitris G Placantonakis; Seth Lieberman; Babak Givi
Journal:  J Neurol Surg Rep       Date:  2022-07-10

6.  Sinonasal glomangiopericytoma causing oncogenic osteomalacia.

Authors:  Gang Gyu Lee; Hun-Jong Dhong; Youn-Soo Park; Young Hyeh Ko
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-05-21       Impact factor: 3.372

7.  Sino-nasal hemangiopericytoma: a case series and systematic literature review.

Authors:  Meir Warman; Adi Syn-Hershko; Oded Cohen; Yevgeny Tzipin; Yonatan Lahav; Idit Tessler
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-01       Impact factor: 2.503

8.  [Sinonasal Hemangiopericytoma: diagnostic and therapeutic challenge].

Authors:  Mohamed Roubal; Aziza Horra; Mohamed Yahya Bajja; Hicham El Ettar; Reda Abada; Sami Rouadi; Mohamed Mahtar; Abdelaziz Janah; Fatmi Kadiri
Journal:  Pan Afr Med J       Date:  2014-05-15

9.  Immunophenotype Heterogeneity in Nasal Glomangiopericytoma.

Authors:  Adriana Handra-Luca; Zakaria Y Abd Elmageed; Christina Magkou; Marick Lae
Journal:  Case Rep Otolaryngol       Date:  2015-08-17

10.  Glomangiopericytoma simulating an intracavernous meningioma.

Authors:  Hussam Abou Al-Shaar; Kristian I Macdonald; Mohamed A Labib
Journal:  Surg Neurol Int       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.